The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value - Quiz - MDSpire

The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value

  • By

  • Jin-feng Pan

  • Yin-zhi Chen

  • Su-ying Wang

  • Zhen-ya Zhao

  • Da-wei Ren

  • Rui Su

  • Xiao-long Jia

  • Jun-hui Jiang

  • Qi Ma

  • October 22, 2025

  • 0 min

Share

Original Source(s)

The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value

  • by Jin-feng Pan, Yin-zhi Chen, Su-ying Wang, Zhen-ya Zhao, Da-wei Ren, Rui Su, Xiao-long Jia, Jun-hui Jiang, Qi Ma

  • October 22, 2025

Related Content

Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study

PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions